Vanguard reports zero holdings in Innovex after realignment
Innovex International Inc: Amendment No. 3 to a Schedule 13G/A filed by The Vanguard Group reports zero shares beneficially owned of Innovex common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Innovex International Inc: Amendment No. 3 to a Schedule 13G/A filed by The Vanguard Group reports zero shares beneficially owned of Innovex common stock. The filing explains an internal realignment on January 12, 2026 that disaggregated subsidiaries and business divisions under SEC Release No. 34-39538, resulting in separate reporting of beneficial ownership. The filing states Vanguard no longer has beneficial ownership over securities held by those subsidiaries. The form is signed by Ashley Grim on 03/27/2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Schedule 13G/A amendment say about INVX ownership by Vanguard?
Why did Vanguard report zero ownership of Innovex (INVX)?
Who signed the Schedule 13G/A amendment for Vanguard on INVX?
Does the amendment indicate any person holds more than 5% of Innovex?
What SEC guidance does Vanguard cite for disaggregated reporting?
AI-generated analysis. How Rhea-AI works. Not financial advice.